563 related articles for article (PubMed ID: 28361503)
1. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.
Seidman DL; Weber S; Cohan D
J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21295. PubMed ID: 28361503
[TBL] [Abstract][Full Text] [Related]
2. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
[TBL] [Abstract][Full Text] [Related]
4. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
Joseph Davey DL; Pintye J; Baeten JM; Aldrovandi G; Baggaley R; Bekker LG; Celum C; Chi BH; Coates TJ; Haberer JE; Heffron R; Kinuthia J; Matthews LT; McIntyre J; Moodley D; Mofenson LM; Mugo N; Myer L; Mujugira A; Shoptaw S; Stranix-Chibanda L; John-Stewart G;
J Int AIDS Soc; 2020 Jan; 23(1):e25426. PubMed ID: 31912985
[TBL] [Abstract][Full Text] [Related]
5. Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women.
Mugwanya KK; John-Stewart G; Baeten J
Expert Opin Drug Saf; 2017 Jul; 16(7):867-871. PubMed ID: 28571500
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.
Matthews LT; Jaggernath M; Kriel Y; Smith PM; O'Neil K; Haberer JE; Hendrix C; Baeten JM; Ware NC; Wirth K; Psaros C; Bangsberg DR; Smit JA
BMJ Open; 2019 Jul; 9(7):e027227. PubMed ID: 31350241
[TBL] [Abstract][Full Text] [Related]
7. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
Krakower DS; Mayer KH
Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
[TBL] [Abstract][Full Text] [Related]
8. Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Women's Health Care in the United States.
Seidman D; Weber S
Obstet Gynecol; 2016 Jul; 128(1):37-43. PubMed ID: 27275793
[TBL] [Abstract][Full Text] [Related]
9. PrEP as Peri-conception HIV Prevention for Women and Men.
Heffron R; Pintye J; Matthews LT; Weber S; Mugo N
Curr HIV/AIDS Rep; 2016 Jun; 13(3):131-9. PubMed ID: 26993627
[TBL] [Abstract][Full Text] [Related]
10. Ending sexual HIV transmission: lessons learned from perinatal HIV.
Weber S; Grant RM
J Assoc Nurses AIDS Care; 2015; 26(5):520-5. PubMed ID: 26096627
[No Abstract] [Full Text] [Related]
11. Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
Joseph Davey DL; Dovel K; Cleary S; Khadka N; Mashele N; Silliman M; Mvududu R; Nyemba DC; Coates TJ; Myer L
BMC Public Health; 2022 Jul; 22(1):1306. PubMed ID: 35799121
[TBL] [Abstract][Full Text] [Related]
12. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
13. Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection.
Stalter RM; Pintye J; Mugwanya KK
Expert Opin Drug Saf; 2021 Nov; 20(11):1367-1373. PubMed ID: 33998936
[No Abstract] [Full Text] [Related]
14. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.
Mugwanya KK; Baeten JM
Expert Opin Drug Saf; 2016; 15(2):265-73. PubMed ID: 26634852
[TBL] [Abstract][Full Text] [Related]
15. Pre-Exposure Prophylaxis for HIV Infection and the Role of the Women's Health Care Provider in HIV Prevention.
Ruppe LB; Spencer LA; Kriebs JM
J Midwifery Womens Health; 2021 May; 66(3):322-333. PubMed ID: 34086396
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
17. Frequency and Predictors of Tenofovir-diphosphate Detection Among Young Kenyan Women in a Real-world Pre-exposure Prophylaxis Implementation Program.
Pintye J; Kinuthia J; Abuna F; Mugwanya K; Lagat H; Dettinger JC; Odinga D; Sila J; Anderson PL; John-Stewart G; Baeten JM
Clin Infect Dis; 2020 Dec; 71(9):e509-e512. PubMed ID: 32109293
[TBL] [Abstract][Full Text] [Related]
18. Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion.
Lee SS; Anderson PL; Kwan TH; Lui GCY; Chan DPC; Wong NS; Lee KCK; Lam TTN
Int J Infect Dis; 2020 May; 94():41-43. PubMed ID: 32173577
[TBL] [Abstract][Full Text] [Related]
19. PrEP for women in Europe: a systematic literature review.
Fitzgerald N; Coltart H; Dominguez L; Flanagan K; Gilleece Y
HIV Med; 2023 Jul; 24(7):765-776. PubMed ID: 37088558
[TBL] [Abstract][Full Text] [Related]
20. Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.
Mofenson LM; Baggaley RC; Mameletzis I
AIDS; 2017 Jan; 31(2):213-232. PubMed ID: 27831952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
